Nj State Employees Deferred Compensation Plan Innoviva, Inc. Transaction History

Nj State Employees Deferred Compensation Plan

  • $800 Million
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 18, 2019
SELL
$10.05 - $14.55 $341,700 - $494,700
-34,000 Closed
0 $0
Q4 2018

Jan 24, 2019
SELL
$13.96 - $18.26 $83,760 - $109,560
-6,000 Reduced 15.0%
34,000 $593,000
Q3 2018

Oct 16, 2018
SELL
$13.63 - $15.7 $640,610 - $737,900
-47,000 Reduced 54.02%
40,000 $610,000
Q2 2018

Aug 02, 2018
SELL
$13.44 - $17.59 $67,200 - $87,950
-5,000 Reduced 5.43%
87,000 $1.2 Million
Q3 2017

Oct 30, 2017
BUY
$12.06 - $14.12 $1.11 Million - $1.3 Million
92,000
92,000 $1.3 Million

Others Institutions Holding INVA

# of Institutions
242
Shares Held
75.8M
Call Options Held
52.8K
Put Options Held
800
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.31B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Nj State Employees Deferred Compensation Plan Portfolio

Follow Nj State Employees Deferred Compensation Plan and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nj State Employees Deferred Compensation Plan, based on Form 13F filings with the SEC.

News

Stay updated on Nj State Employees Deferred Compensation Plan with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email